Trials / Completed
CompletedNCT00422617
Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Uni-Pharma · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
An open-label, multicentre study to evaluate the efficacy and safety of one course of weekly intramuscular administration of Amevive in Taiwan patients with chronic plaque psoriasis
Detailed description
The purpose of the present study is to establish the efficacy and safety of one course of once weekly 15 mg intramuscular (IM) administration of AMEVIVE in an alternate study population and to address the issue of peak time to response by measuring the proportion of patients achieving a ≥ 75% reduction in PASI at any time after completion of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alefacept (Amevive) |
Timeline
- Start date
- 2005-01-01
- Completion
- 2005-11-01
- First posted
- 2007-01-17
- Last updated
- 2007-01-17
Source: ClinicalTrials.gov record NCT00422617. Inclusion in this directory is not an endorsement.